Goodsurance

Policy & oversight

CMS Says It Stopped 1.6 Billion Dollars in Potentially Fraudulent Medicare Lab Payments Using Artificial Intelligence

The agency credits machine learning and advanced analytics for faster detection of suspicious laboratory billing, with results spanning revocations, payment suspensions, and recovered overpayments.

By the Goodsurance editorial teamSeptember 1, 2026

The Centers for Medicare and Medicaid Services announced that enforcement actions have halted more than 1.6 billion dollars in potentially improper Medicare laboratory payments since the start of the current administration. The agency attributes the results to advanced analytics, including artificial intelligence and machine-learning models, that scan Medicare fee-for-service claims for unusual billing patterns in near real time.

CMS broke down the total across four categories: 732 million dollars in savings and recovered amounts from revoking 157 fraudulent lab providers from the Medicare program; more than 500 million dollars in payments halted through 185 active payment suspensions; 276 million dollars recouped from 442 identified overpayments; and 127 million dollars in payments blocked because of 85 law enforcement referrals.

1.6 billion dollars in Medicare lab fraud stopped. CMS says AI flagged suspicious billing faster than traditional review methods.

In one example cited by CMS, analysts detected suspicious billing from a Texas-based laboratory within weeks of the lab beginning operations. A payment suspension blocked more than 150 thousand dollars in additional suspect payments before the provider was revoked from Medicare.

For Medicare beneficiaries, improper laboratory billing raises overall program costs over time, which can put indirect upward pressure on Part B premiums. CMS said it will continue using AI-based surveillance tools to flag unusual billing activity as it emerges.

In plain words

Medicare's main agency stopped 1.6 billion dollars in bad laboratory payments using computer tools that look for unusual billing. The money was saved or recovered four different ways. First, 157 fake lab companies were kicked out of Medicare, stopping 732 million dollars. Second, payments to 185 suspicious labs were frozen, saving more than 500 million dollars. Third, 276 million dollars was taken back after 442 overbillings were found. Fourth, 127 million dollars was blocked after tips were shared with law enforcement.

In one case, a Texas lab started billing and was caught within weeks. The agency froze its payments and then removed it from Medicare.

Lab fraud matters to Medicare users because it pushes up overall program costs over time, which can affect what Part B charges in future years.

Source: CMS
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

A Pending CMS Rule Would Set Hard Time Limits on Drug Prior Authorization Decisions in Medicare Advantage

CMS's proposed interoperability and drug prior authorization rule (CMS-0062-P) would require Medicare Advantage and other plans to resolve urgent drug requests within 24 hours and standard requests within 72 hours.

September 8, 2026

Policy & oversight

Texas Receives 281.3 Million Dollars, the Program's Largest State Award, to Expand Rural AI Telehealth

Texas's first-year Rural Health Transformation grant leads all states and centers on artificial intelligence, telehealth infrastructure, and growing the rural provider workforce.

September 7, 2026

Policy & oversight

CMS Opens the FY 2028 Window for Hospitals Seeking Add-On Medicare Pay for New Technologies

A Federal Register notice invites hospitals and manufacturers to apply for supplemental Medicare payments when brand-new devices or drugs enter hospital care, with a virtual public meeting set for December and comments due by mid-December.

September 7, 2026

Policy & oversight

California Receives 233.6 Million Dollars in Federal Rural Health Grants for Telehealth and Workforce

California's first-year Rural Health Transformation Program award will fund expanded telehealth, rural workforce development, and new care models for communities far from hospitals.

September 7, 2026

Policy & oversight

Virginia Receives 122 Million Dollars in Federal Rural Health Grants to Expand Telehealth, Paramedics, and Workforce Training

CMS distributed the first portion of Virginia's first-year Rural Health Transformation Program award on August 28, with funds directed toward remote monitoring, community paramedicine, maternal care, and allied health career pipelines.

September 6, 2026

Policy & oversight

OIG: Conflicting Medicare Rules Allowed an Estimated 380 Million Dollars in Organ Payments Not Required by Federal Law

A federal audit completed September 1 found that CMS guidance permitted reimbursements to certified transplant centers for organs never implanted in Medicare patients, diverging from what federal statute requires.

September 6, 2026